PH30130A - Lacidipine for the treatment of arteriosclerosis - Google Patents

Lacidipine for the treatment of arteriosclerosis

Info

Publication number
PH30130A
PH30130A PH43915A PH43915A PH30130A PH 30130 A PH30130 A PH 30130A PH 43915 A PH43915 A PH 43915A PH 43915 A PH43915 A PH 43915A PH 30130 A PH30130 A PH 30130A
Authority
PH
Philippines
Prior art keywords
lacidipine
arteriosclerosis
treatment
pyridinedicarboyxlic
dimethylethoxy
Prior art date
Application number
PH43915A
Other languages
English (en)
Inventor
Giovanni Gaviraghi
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of PH30130A publication Critical patent/PH30130A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PH43915A 1991-02-13 1992-02-12 Lacidipine for the treatment of arteriosclerosis PH30130A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910359A IT1244728B (it) 1991-02-13 1991-02-13 Impiego medicamentoso di derivati diidropiridinici

Publications (1)

Publication Number Publication Date
PH30130A true PH30130A (en) 1997-01-21

Family

ID=11358541

Family Applications (1)

Application Number Title Priority Date Filing Date
PH43915A PH30130A (en) 1991-02-13 1992-02-12 Lacidipine for the treatment of arteriosclerosis

Country Status (23)

Country Link
US (1) US5455257A (it)
EP (2) EP0499920B1 (it)
JP (1) JP2996725B2 (it)
KR (1) KR100188171B1 (it)
AT (1) ATE157004T1 (it)
AU (1) AU646929B2 (it)
CA (1) CA2103805C (it)
CZ (1) CZ281760B6 (it)
DE (1) DE69221649T2 (it)
DK (1) DK0499920T3 (it)
ES (1) ES2106098T3 (it)
GR (1) GR3024661T3 (it)
IE (1) IE920453A1 (it)
IL (1) IL100928A (it)
IT (1) IT1244728B (it)
MX (1) MX9200600A (it)
NO (1) NO303713B1 (it)
PH (1) PH30130A (it)
RU (1) RU2136279C1 (it)
SG (1) SG59972A1 (it)
UA (1) UA27780C2 (it)
WO (1) WO1992014460A1 (it)
ZA (1) ZA921006B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69627137T2 (de) * 1995-06-07 2003-12-04 Ivax Research, Inc. Verwendung von pentosan polysulfat zur behandlung von narben in chronischer fortschreitender gefässerkrankungen
RU2287327C2 (ru) * 2003-10-16 2006-11-20 Юрий Антонович Кошелев Средство для лечения и профилактики атеросклероза
EP1868577A4 (en) * 2005-04-15 2009-12-09 Reddys Lab Inc Dr Lacidipine PARTICLE
WO2007096694A1 (es) * 2006-02-22 2007-08-30 Ramiro Vergara Asociacion de principios activos neuroactivadores

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597163A (ja) * 1982-07-02 1984-01-14 Yamanouchi Pharmaceut Co Ltd 抗動脈硬化剤
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition

Also Published As

Publication number Publication date
RU2136279C1 (ru) 1999-09-10
HK1009585A1 (en) 1999-06-04
CA2103805A1 (en) 1992-08-14
DK0499920T3 (da) 1998-01-26
UA27780C2 (uk) 2000-10-16
WO1992014460A1 (en) 1992-09-03
IL100928A (en) 1997-02-18
AU646929B2 (en) 1994-03-10
NO303713B1 (no) 1998-08-24
KR100188171B1 (en) 1999-06-01
CA2103805C (en) 2002-09-17
ZA921006B (en) 1992-12-30
DE69221649T2 (de) 1997-12-11
GR3024661T3 (en) 1997-12-31
CZ165093A3 (en) 1994-03-16
ATE157004T1 (de) 1997-09-15
DE69221649D1 (de) 1997-09-25
JPH06505002A (ja) 1994-06-09
NO932874D0 (no) 1993-08-12
CZ281760B6 (cs) 1997-01-15
EP0499920A1 (en) 1992-08-26
IT1244728B (it) 1994-08-08
EP0499920B1 (en) 1997-08-20
US5455257A (en) 1995-10-03
ITMI910359A1 (it) 1992-08-13
EP0576433A1 (en) 1994-01-05
ES2106098T3 (es) 1997-11-01
AU1223192A (en) 1992-09-15
JP2996725B2 (ja) 2000-01-11
NO932874L (no) 1993-08-12
IE920453A1 (en) 1992-08-12
MX9200600A (es) 1992-10-30
SG59972A1 (en) 1999-02-22
ITMI910359A0 (it) 1991-02-13

Similar Documents

Publication Publication Date Title
DE69324036D1 (de) Dentales implantat
BG60677B1 (en) Fungicide oxazolidinones
DE68927160D1 (de) Verwendung von N-Butyl-Deoxynojirimycin zur Behandlung von Herpes
DE69300062D1 (de) Verfahren zur Herstellung von N-Methoxyderivate von 4-Hydroxy-2,2,6,6-Tetramethylpiperidin und 2,2,6,6-Tetramethyl-4-Piperidon.
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
KR100188171B1 (en) Use of lacidipine for the treatment of arteriosclerosis
EE03953B1 (et) 2-fenüül-1,2-bensisoseleenasool-3(2H)-ooni kasutamine farmatseutilise preparaadi valmistamisel Alzheimeri tõve raviks
EP0796096A4 (en) 4,4- (DISUBSTITUTED) CYCLOHEXAN-1-CARBOXYLATE MONOMERS AND RELATED COMPOUNDS
EE04235B1 (et) Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks
DE59310153D1 (de) Verfahren zur Herstellung von 4-Hydroxy-2.2.6.6-tetramethylpiperidin
RU93054780A (ru) Применение лацидипина для лечения артериосклероза
DE69231883D1 (de) 4-(1,1-Dialkoxycarbonyl-Alkyl)Azetidin-2-on-Derivate zur Herstellung von 4-(1-Carboxy-Alkyl)Azetidin-2-on-Derivaten
NO920313L (no) Fremgangsmaate for fremstilling av rasemisk og optisk aktiv 1,2,3,4-tetrahydroisokinolin-3-karbonsyre samt forprodukter derav
ITRM910211A0 (it) Impianto dentale endosseo.
FR2720624B1 (fr) Implant dentaire et éléments auxiliaires amovibles s'y adaptant.
FR2695822B1 (fr) Implant dentaire evolue et evolutif.
DE69215106D1 (de) Zahnimplantat
ATE122352T1 (de) 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen.
NO924767L (no) Anordning for bedring av miljö i munnhulen ved tannbehandling
EP0800393A4 (en) MONOMERS OF 4.4- (DISUBSTITUTED) CYCLOHEXAN-1-ONE AND COMPOUNDS THEREOF
NO960777D0 (no) Anvendelse av N-alkylerte 1,4-dihydropyridin dikarboksylsyreestere som medikamenter
ES1023915Y (es) Implante dental.
ATE144894T1 (de) Zahnimplantat
BR7201445U (pt) Implante dental
DE69616484D1 (de) Verwendung vom 3-Alpha-Hydroxy-5Alpha-Androsta-16-ene als Arzneimittel